Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,008,680 | 246,199 | 0 | N/A | 8,688 |
| Marketable Securities | 1,053,263 | 94,455 | 0 | N/A | N/A |
| Receivables | 39,166 | 38,766 | 0 | N/A | N/A |
| Other current assets | 595,789 | 452,652 | 0 | 0 | 0 |
| TOTAL | $2,696,898 | $832,072 | $0 | $N/A | $8,754 |
| Non-Current Assets | |||||
| PPE Net | 12,368,080 | 10,842,050 | 0 | N/A | 3 |
| Investments And Advances | 916,641 | 678,412 | 0 | 0 | 0 |
| Intangibles | 28,666 | 51,724 | 0 | 0 | 0 |
| Other Non-Current Assets | 10,003 | 45,634 | 0 | 0 | 0 |
| TOTAL | $13,323,390 | $11,617,820 | $N/A | $N/A | $3 |
| Total Assets | $16,020,290 | $12,449,890 | $0 | $N/A | $8,757 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 291,199 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 155,741 | 42,218 | 0 | 0 | 1,880 |
| Accrued Expenses | 152,146 | N/A | 0 | N/A | 779 |
| TOTAL | $307,887 | $333,417 | $0 | $N/A | $2,659 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,816,584 | 5,975,040 | 0 | N/A | N/A |
| Other Non-Current Liabilities | -726,914 | -112,884 | -140,126 | 0 | 0 |
| TOTAL | $5,816,584 | $5,975,040 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,124,471 | $6,308,457 | $0 | $N/A | $2,659 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 607,111 | N/A | N/A | N/A | N/A |
| Common Shares | 102 | N/A | 0 | N/A | 26 |
| Retained earnings | 1,920,635 | 2,825,212 | 0 | N/A | -319,529 |
| Other shareholders' equity | 5,111,114 | 3,320,226 | 0 | 0 | -380 |
| TOTAL | $9,895,815 | $6,141,438 | $0 | $N/A | $6,098 |
| Total Liabilities And Equity | $16,020,286 | $12,449,895 | $0 | $0 | $8,757 |